| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.6 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |